Le-Shi International Holdings (01529.HK) subsidiary plans to acquire 100% equity of Bozhou Le Lao Hao Pharmaceutical.

Zhixin Finance APP News, REX Global Holdings Limited (01529.HK) announced that on July 8, 2025, the Group entered into a share transfer agreement through its indirect wholly-owned subsidiary to acquire 100% equity of Lao Hao Pharmaceutical Co., Ltd. in Bozhou (target company) for a total consideration of RMB 900,000. The consideration was determined after fair negotiation between the contracting parties. The Board of Directors expects that this acquisition will not have any significant adverse impact on the financial condition or operations of the Group in the short term. Upon completion, the target company will become an indirect wholly-owned subsidiary of the Company, and its financial performance will be consolidated in the Group's comprehensive financial statements.